Real-World data reveals Tezepelumab's impact on severe asthma
NCT ID NCT06455462
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 24 times
Summary
This study looked back at the medical records of 352 adults with severe asthma who received tezepelumab in UK clinics. Researchers tracked how many asthma attacks patients had in the year after starting the drug compared to the year before. The goal was to see how well the treatment works in real life, outside of controlled trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Birmingham, United Kingdom
-
Research Site
Liverpool, United Kingdom
-
Research Site
London, United Kingdom
-
Research Site
Newcastle, United Kingdom
-
Research Site
Plymouth, United Kingdom
-
Research Site
Southampton, United Kingdom
Conditions
Explore the condition pages connected to this study.